FDA

The recommendation applies to people 65 years and older, those 18 to 64 who are at high risk of severe COVID and those whose work or institutional exposure puts them at high COVID risk.

Advisers to the Food and Drug Administration supported boosters of the Pfizer-BioNTech COVID-19 vaccine for a smaller group of people after they voted against recommending it for anyone 16 and older.

The Texas Poison Center has received 260 calls with ivermectin poisoning. Ivermectin is a livestock dewormer, and people are using it to prevent or treat a coronavirus infection.

The approval replaces the emergency use authorizations granted last December and could make it easier for employers, the military and universities to mandate vaccination.

The FDA amended its emergency use authorizations for the Pfizer and Moderna vaccines to allow for an additional dose for some immunocompromised people.

Moderna dijo que presentará los resultados de sus estudios más recientes a la Administración de Alimentos y Medicamentos y otros reguladores globales en junio.

Moderna said it will submit the results of its study to the Food and Drug Administration and regulators in other countries next month.

The company said in late March that clinical trials showed the vaccine elicits "100% efficacy and robust antibody responses" in adolescents.

The Food and Drug Administration is working on a playbook for how it could greenlight vaccine tweaks. Studies in hundreds of people, rather than tens of thousands, seem likely.

Advisers to the Food and Drug Administration voted 20-0 to recommend that the agency authorize Moderna's vaccine for emergency use during the pandemic. There was a single abstention.